Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|12|3|436-443

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.3, 2013-05, pp. : 436-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR Studies for the Pharmacological Inhibition of Glycogen Synthase Kinase-3

By  

Medicinal Chemistry, Vol. 3, Iss. 4, 2007-07 ,pp. : 393-417

Bentham Science Publishers

Access to resources Recommend Favorite

Role of glycogen synthase kinase-3 in l-DOPA-induced neurotoxicity

By Koh Seong-Ho   Kim Seung Hyun   Kim Hee-Tae  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 11, 2009-11 ,pp. : 1359-1368

Informa Healthcare

Access to resources Recommend Favorite

Regulation of Skeletal Muscle Plasticity by Glycogen Synthase Kinase-3beta;: A Potential Target for the Treatment of Muscle Wasting

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3276-3298

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1377-1388

Bentham Science Publishers

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite